1. Pastore G, Massimiliano M, Marcantoni L, et al. ECG parameters predict left ventricular conduction delay in patients with left ventricular dysfunction. Heart Rhythm 2016;13:2289–2296.

1. Pastore GMassimiliano MMarcantoni L, et al. ECG parameters predict left ventricular conduction delay in patients with left ventricular dysfunction. Heart Rhythm 2016;13:2289–2296.)| false
• Search Google Scholar
• Export Citation

2. Pedro BM, Alves J, Cripps P, et al. Association of QRS duration and survival in dogs with dilated cardiomyopathy: a retrospective study of 266 clinical cases. J Vet Cardiol 2011;13:243–249.

2. Pedro BMAlves JCripps P, et al. Association of QRS duration and survival in dogs with dilated cardiomyopathy: a retrospective study of 266 clinical cases. J Vet Cardiol 2011;13:243–249.)| false
• Search Google Scholar
• Export Citation

3. Tilley LP. Analysis of the canine P-QRS-T deflections. In: Cann CC, Hunsberger SL, eds. Essentials of canine and feline electrocardiography. 3rd ed. Malvern, Pa: Lea & Febiger, 1992;72–74.

3. Tilley LP. Analysis of the canine P-QRS-T deflections. In: Cann CCHunsberger SL, eds. Essentials of canine and feline electrocardiography. 3rd ed. Malvern, Pa: Lea & Febiger, 1992;72–74.)| false
• Search Google Scholar
• Export Citation

4. Gooding JP, Robinson WF, Mews GC. Echocardiographic characterization of dilatation cardiomyopathy in the English Cocker Spaniel. Am J Vet Res 1986;47:1978–1983.

4. Gooding JPRobinson WFMews GC. Echocardiographic characterization of dilatation cardiomyopathy in the English Cocker Spaniel. Am J Vet Res 1986;47:1978–1983.)| false
• Search Google Scholar
• Export Citation

5. Roden DM. Mechanisms and management of proarrhythmia. Am J Cardiol 1998;82:49I–57I.

5. Roden DM. Mechanisms and management of proarrhythmia. Am J Cardiol 1998;82:49I–57I.)| false
• Search Google Scholar
• Export Citation

6. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 2009;119:2516–2525.

6. Anter EJessup MCallans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 2009;119:2516–2525.)| false
• Search Google Scholar
• Export Citation

7. Georgiopoulou VV, Kalogeropoulos AP, Giamouzis G, et al. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Circ Heart Fail 2009;2:90–97.

7. Georgiopoulou VVKalogeropoulos APGiamouzis G, et al. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Circ Heart Fail 2009;2:90–97.)| false
• Search Google Scholar
• Export Citation

8. Button C, Gross DR, Johnston JT, et al. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs. Am J Vet Res 1980;41:1230–1237.

8. Button CGross DRJohnston JT, et al. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs. Am J Vet Res 1980;41:1230–1237.)| false
• Search Google Scholar
• Export Citation

9. Zafari AM, Zarter SK, Heggen V, et al. A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol 2004;44:846–852.

9. Zafari AMZarter SKHeggen V, et al. A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol 2004;44:846–852.)| false
• Search Google Scholar
• Export Citation

10. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Rev Esp Cardiol (Engl Ed) 2016;69:176.

10. Priori SGBlomström-Lundqvist CMazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Rev Esp Cardiol (Engl Ed) 2016;69:176.)| false
• Search Google Scholar
• Export Citation

11. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of acute myocardial infarction). Circulation 1996;94:2341–2350.

11. Ryan TJAnderson JLAntman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of acute myocardial infarction). Circulation 1996;94:2341–2350.)| false
• Search Google Scholar
• Export Citation

12. Sadowski ZP, Alexander JH, Skrabucha B, et al. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J 1999;137:792–798.

12. Sadowski ZPAlexander JHSkrabucha B, et al. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J 1999;137:792–798.)| false
• Search Google Scholar
• Export Citation

13. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med 1995;333:77–82.

13. Singh SNFletcher RDFisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med 1995;333:77–82.)| false
• Search Google Scholar
• Export Citation

14. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive VT. J Am Coll Cardiol 1996;27:67–75.

14. Levine JHMassumi AScheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive VT. J Am Coll Cardiol 1996;27:67–75.)| false
• Search Google Scholar
• Export Citation

15. Kraus MS, Thomason JD, Fallaw TL, et al. Toxicity in Doberman Pinschers with ventricular arrhythmias treated with amiodarone (1996–2005). J Vet Intern Med 2009;23:1–6.

15. Kraus MSThomason JDFallaw TL, et al. Toxicity in Doberman Pinschers with ventricular arrhythmias treated with amiodarone (1996–2005). J Vet Intern Med 2009;23:1–6.)| false
• Search Google Scholar
• Export Citation

16. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 2002;288:3035–3038.

16. Weisfeldt MLBecker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 2002;288:3035–3038.)| false
• Search Google Scholar
• Export Citation

17. Fletcher DJ, Boller M, Brainard BM, et al. RECOVER evidence and knowledge gap analysis on veterinary CPR. Part 7: clinical guidelines. J Vet Emerg Crit Care (San Antonio) 2012;22(suppl 1):S102–S131.

17. Fletcher DJBoller MBrainard BM, et al. RECOVER evidence and knowledge gap analysis on veterinary CPR. Part 7: clinical guidelines. J Vet Emerg Crit Care (San Antonio) 2012;22(suppl 1):S102–S131.)| false
• Search Google Scholar
• Export Citation

18. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417–1424.

18.Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417–1424.)| false
• Search Google Scholar
• Export Citation

19. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent the recurrence of AF. N Engl J Med 2000;342:913–920.

19. Roy DTalajic MDorian P, et al. Amiodarone to prevent the recurrence of AF. N Engl J Med 2000;342:913–920.)| false
• Search Google Scholar
• Export Citation

20. Kochiadakis GE, Igoumenidis NE, Marketou ME, et al. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart 2000;84:251–257.

20. Kochiadakis GEIgoumenidis NEMarketou ME, et al. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart 2000;84:251–257.)| false
• Search Google Scholar
• Export Citation

21. Shinagawa K, Shiroshita-Takeshita A, Schram G, et al. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107:1440–1446.

21. Shinagawa KShiroshita-Takeshita ASchram G, et al. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107:1440–1446.)| false
• Search Google Scholar
• Export Citation

22. Bright JM, Martin J, Mama K. A retrospective evaluation of transthoracic biphasic electrical cardioversion for atrial fibrillation in dogs. J Vet Cardiol 2005;7:85–96.

22. Bright JMMartin JMama K. A retrospective evaluation of transthoracic biphasic electrical cardioversion for atrial fibrillation in dogs. J Vet Cardiol 2005;7:85–96.)| false
• Search Google Scholar
• Export Citation

23. Calvert CA, Pickus CW, Jacobs GJ, et al. Signalment, survival, and prognostic factors in Doberman Pinschers with endstage cardiomyopathy. J Vet Intern Med 1997;11:323–326.

23. Calvert CAPickus CWJacobs GJ, et al. Signalment, survival, and prognostic factors in Doberman Pinschers with endstage cardiomyopathy. J Vet Intern Med 1997;11:323–326.)| false
• Search Google Scholar
• Export Citation